Treatment of experimental cutaneous leishmaniasis with liposome-intercalated amphotericin B.
AUTOR(ES)
Panosian, C B
RESUMO
The therapeutic efficacy of a liposomal preparation of amphotericin B was evaluated in two murine models of cutaneous leishmaniasis. No significant decrease in tissue parasite density was observed in C57BL/6 mice after systemic treatment instituted seven days after footpad inoculation with Leishmania tropica; in contrast, BALB/c mice showed a modest response.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=185609Documentos Relacionados
- Efficacy of liposome-intercalated amphotericin B in the treatment of systemic candidiasis in mice.
- Effect of lipid composition and liposome size on toxicity and in vitro fungicidal activity of liposome-intercalated amphotericin B.
- Activity of liposomal amphotericin B against experimental cutaneous leishmaniasis.
- Efficacious Topical Treatment for Murine Cutaneous Leishmaniasis with Ethanolic Formulations of Amphotericin B
- In vitro antifungal activities of amphotericin B and liposome-encapsulated amphotericin B.
